rimantadine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, S | 2 |
| Stgelais, C | 1 |
| Owsianka, AM | 1 |
| Patel, AH | 1 |
| Rowlands, D | 2 |
| Harris, M | 2 |
| Wozniak, AL | 1 |
| Yi, M | 1 |
| Lemon, SM | 1 |
| Weinman, SA | 1 |
2 other studies available for rimantadine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Ce | 2008 |
Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
Topics: Amantadine; Antifungal Agents; Antiviral Agents; Blotting, Western; Electroporation; Hepacivirus; He | 2010 |